Protocol Details: Dose 1 mg (10 units on 1ml insulin syringe) Timing AM Frequency 5 days on, 2 days off Duration 8 weeks on, 8 weeks off Administration SubQ injection Source Jays Note: 5-Amino-1MQ works by stopping NAD+ from being consumed at the source
When used concurrently with insulin or insulin secretagogues such as sulfonylureas or meglitinides, the risk of hypoglycemia may be increased, particularly during the initiation of therapy or following dose escalations
Heffernan M, Thorburn AW, Fam B, Summers R, Conway-Campbell B, Waters MJ, Ng FM
Keep the injection area of your skin clean and dry, in order to prevent irritation, bruising and any other potential risks
This product is not intended to diagnose, treat, cure, or prevent any disease.
NAD+ services require consultation and approval, and the best option depends on your goals, comfort level, and medical review